Mauna Kea Technologies Congratulates Stanford Health Care on Completing 100
Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces the achievement of a key milestone by the clinical care team at Stanford Health Care, which has surpassed 100 cases for CellTolerance tests using the Cellvizio platform for patients with suspected food intolerance.
An estimated 12% of the U.S. population suffers from IBS, and in several clinical studies using pCLE, it has been proven that more than 50% of those patients could suffer from food intolerances that can only be characterized by the real-time visualization of the intestinal barrier with Cellvizio during a food challenge. Linda Nguyen, M.D., Interim Chief, Gastroenterology & Hepatology and Clinical Professor of Medicine, Laura Pace, M.D., Clinical Assistant Professor of Medicine, and Sean Spencer, M.D. Ph.D., Instructor of Medicine, are leading the team of health care providers who are helping IBS patients end the circular loop of trying and repeatedly failing to identify and address the cause of their food-related IBS symptoms.
'With every CellTolerance test, we are using this cutting-edge technology to provide our patients with gut-specific, personalized answers. Reaching our first 100 cases is not just a milestone for our team, but a beacon of hope for all of our patients struggling with food intolerances. This program is a game-changer, and I am incredibly proud of our team for leading the charge in this new era of digestive health," said Dr. Sean Spencer at Stanford Medicine.
Sacha Loiseau, Ph.D., Chairman and Chief Executive Officer of Mauna Kea Technologies, stated:"CellTolerance is bringing answers to the millions of patients seeking resolution of their food-related IBS symptoms, and I extend a huge congratulations to the team at Stanford for their work in implementing CellTolerance on the Cellvizio platform and achieving this fantastic milestone. We are seeing strong growth and adoption of CellTolerance worldwide, underscoring the unique value proposition of the CellTolerance test for physicians and the desire of patients to find a solution that truly addresses their unmet needs."
***
About Mauna Kea Technologies
Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio® platform is used globally across a wide range of medical specialties and is making a transformative change in the way physicians diagnose and treat patients. For more information, visit www.maunakeatech.com.
Disclaimer
This press release contains forward-looking statements about Mauna Kea Technologies and its business. All statements other than statements of historical fact included in this press release, including, but not limited to, statements regarding Mauna Kea Technologies' financial condition, business, strategies, plans and objectives for future operations are forward-looking statements. Mauna Kea Technologies believes that these forward-looking statements are based on reasonable assumptions. However, no assurance can be given that the expectations expressed in these forward-looking statements will be achieved. These forward-looking statements are subject to numerous risks and uncertainties, including those described in Chapter 2 of Mauna Kea Technologies' 2024 Annual Report filed with the Autorité des marchés financiers (AMF) on April 30, 2025, which is available on the Company's website (www.maunakeatech.fr), as well as the risks associated with changes in economic conditions, financial markets and the markets in which Mauna Kea Technologies operates. The forward-looking statements contained in this press release are also subject to risks that are unknown to Mauna Kea Technologies or that Mauna Kea Technologies does not currently consider material. The occurrence of some or all of these risks could cause the actual results, financial condition, performance or achievements of Mauna Kea Technologies to differ materially from those expressed in the forward-looking statements. This press release and the information contained herein do not constitute an offer to sell or subscribe for, or the solicitation of an order to buy or subscribe for, shares of Mauna Kea Technologies in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The distribution of this press release may be restricted in certain jurisdictions by local law. Persons into whose possession this document comes are required to comply with all local regulations applicable to this document.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
COVID levels rising in much of U.S., with highest in West, CDC says
The summer surge of COVID-19 doesn't appear to be slowing down — instead, a key indicator for tracking the spread of the virus has increased, according to the latest data from the Centers for Disease Control and Prevention. In an update shared Friday, official data showed wastewater activity for COVID-19 is now at a "moderate" level nationwide, up from "low" the previous week. Wastewater levels for the virus are currently the highest in the Western U.S., the data also showed. States in this region showing high levels include: Alaska, California, Colorado, Nevada and Utah. "Wastewater monitoring can detect viruses spreading from one person to another within a community earlier than clinical testing and before people who are sick go to their doctor or hospital," the CDC notes. "If you see increased wastewater viral activity levels, it might indicate that there is a higher risk of infection." Other metrics are also showing increases in the illness. As of Tuesday, the CDC estimates COVID-19 infections are growing or likely growing in 45 states, which is up from 40 states last week. And although the weekly percentage of emergency room visits for COVID-19 is overall low — compared to the week before, ER visits for the infection have also risen from last week. As the nation saw the number of COVID cases increase last month, CBS News chief medical correspondent Dr. Jon LaPook told "CBS Mornings" that this is typical of what we've come to understand about summer spikes. "We now know that there's a winter spike and then there's a summer spike," he said at the time. "And every year, the number of deaths, the number of hospitalizations, is gradually going down each season. So that's the good news." But, people shouldn't ignore the increases, he said, adding if it strikes — especially those vulnerable like the elderly, young people and those immunocompromised — as they can still get really sick. Global stock markets react to Trump's sweeping tariffs in effect now Sean "Diddy" Combs wants to go back to Madison Square Garden in the future, attorney says Israel's Security Cabinet approves plan to take over Gaza City Solve the daily Crossword
Associated Press
a day ago
- Associated Press
Prolon L-Protein Bar Sets New Standard for Clean, Age-Supportive Nutrition
L-Nutra's newest innovation is a plant-based protein bar formulated to support muscle health and slow age-related nutritional triggers, not just fuel fitness L-Nutra, a global leader in nutrition technology and longevity science, is once again redefining what precision nutrition can do with the launch of the Prolon® L-Protein Bar — a clean, plant-based bar scientifically formulated to provide the perfect balance of amino acids from plant-based sources to support both muscle health and healthy aging, not just workouts. Most protein products today are focused on quantity — more grams, more calories, more bulk. But emerging longevity science shows that too much of the wrong kind of protein can accelerate aging by overstimulating key growth pathways like IGF-1 and mTOR. On the other hand, too little protein — especially in strict vegan diets — may fail to adequately support muscle maintenance and overall strength. Achieving this balance is critical: while excessive protein, particularly from animal sources, may overstimulate pro-aging pathways, too little protein can undermine strength, energy, and overall resilience. The L-Protein Bar is carefully designed to navigate this middle path — delivering the right nutrients, in the right amounts, from the right sources. Now part of the Prolon suite of clinically informed nutrition tools, the L-Protein Bar continues L-Nutra's mission to create smarter everyday nutrition solutions rooted in more than two decades of research. 'If you want to live a long and healthy life, you need to slow the rate of aging every day — and that starts with what you eat,' says Dr. Joseph Antoun, a Harvard- and Johns Hopkins-trained physician and CEO of L-Nutra. 'Protein can accelerate aging if you're choosing the wrong types or the wrong amounts. Our novel L-Protein Bar, rooted in more than 25 years of longevity science, strikes the optimal balance: enough to support muscle strength, but not so much that it speeds up the aging process. And unlike most protein products, there are no hidden ingredients. We pride ourselves on quality ingredients and transparency in how we make our products.' A Protein Bar Built for the Future of Health Formulated by scientists at the USC Longevity Institute, the Prolon L-Protein Bar includes a diverse blend of plant-based proteins (from black beans, chickpeas, and peas) and is fortified with L-methionine, an essential amino acid typically low or missing in vegan diets and other vegan protein supplements. This targeted formulation is designed to maintain a balanced growth factor response while delivering complete protein support for muscle and tissue health. Each bar contains 14 grams of protein, only 170 calories, and is made without added sugars, sugar alcohols, or artificial sweeteners. Instead, it's naturally sweetened with whole dates for a rich flavor and more balanced glycemic response. How Our Protein Bar Redefines the Standard The bar launches in its first flavor, Chocolate Coated, featuring a 100% dark chocolate layer and a rich, satisfying taste. Additional flavors are planned as part of Prolon's expanding Longevity Nutrition platform — a product suite designed to help people integrate clinically-backed, health-supportive nutrition into daily life. The Prolon L-Protein Bar is now available for purchase at About L-Nutra L-Nutra is the global leader in nutri-technology, advancing the discovery, design, and delivery of clinically tested Nutrition for Longevity and Nutrition as Medicine programs. With over 134 issued patents and more than 47 published clinical studies in collaboration with 18 leading universities, L-Nutra's innovations harness the power of plant-based nutrition to support healthy aging, metabolic reset, and cellular rejuvenation. Through its consumer division, Prolon, L-Nutra offers a suite of fasting and longevity-focused products designed to reduce biological age and support whole-body wellness. Its medical division, L-Nutra Health, delivers clinically backed programs aimed at supporting the remission and regression of chronic conditions like type 2 diabetes and metabolic conditions through food-led, lifestyle medicine interventions. Together, these branches reflect L-Nutra's mission to transform what's possible through nutrition and longevity science. To learn more, visit Media Contact Melanie Murphy Richter [email protected] ### SOURCE: L-Nutra Copyright 2025 EZ Newswire
Business Wire
a day ago
- Business Wire
BerryDunn Showcases Thought Leadership and Expertise at 2025 MESC Conference
PORTLAND, Maine--(BUSINESS WIRE)--BerryDunn, a full-service accounting, tax, and consulting firm, will return for the 25th year to the Medicaid Enterprise Systems Conference (MESC), taking place August 11 – 14 in Milwaukee, WI. The firm is a leading voice in Medicaid and other Health and Human Services (HHS) policy, program excellence, and healthcare data analytics, with decades of hands-on experience supporting states and territories. The MESC brings together territorial, state, federal, and private-sector leaders to discuss and collaborate on Medicaid and other HHS systems and the policies that affect them. Hot topics at MESC 2025 include systems optimization, healthcare IT strategy, and a strong emphasis on modernization, interoperability, and health equity. 'The urgency for the healthcare community to prioritize the well-being of those they serve—while modernizing systems, ensuring compliance, and driving innovation—has never been greater,' says Zachary Rioux, Principal at BerryDunn. 'Our team is deeply committed to helping clients build future-ready solutions that are both strategic and sustainable. We've supported agencies in preparing for and responding to major federal legislation like the One Big Beautiful Bill Act (OBBBA), and we continue to guide clients through the evolving policy landscape.' BerryDunn's involvement with industry associations, governance boards, and conferences enables the consulting team to anticipate and help clients respond to developments like the recent State Health Officials (SHO) letter #25003 and upcoming changes to the Medicaid Information Technology Architecture (MITA). MESC is a powerful gathering of ideas, experience, and purpose—and BerryDunn is proud to be part of a community that's driving meaningful change in healthcare. Several BerryDunn professionals will play a leading role in this year's conference presentations, including: Alexandra Nardo and Robert Morey will speak during a session titled 'Building the Foundation for AI: Puerto Rico's AI Readiness Roadmap.' The session explores the Puerto Rico Medicaid Program's assessment, planning process, and roadmap in support of the agency's AI considerations. Delivering purposeful results through partnership, Amber Davis, a Manager in BerryDunn's Medicaid Practice Group, will moderate a session on 'Advancing Medicaid Innovation through the CMS Leverage & Reuse Initiative.' This session will explore how states and territories are collaborating to drive efficiency, reduce costs, and accelerate innovation in Medicaid technology. Partnering with CMS and the leadership team at the Puerto Rico Medicaid Program (PRMP), Nikki Welch, Manager at BerryDunn, will present 'Leveraging Organizational Change Management (OCM) Maturity Results to Enhance Medicaid Outcomes.' This session highlights PRMP's journey to integrate OCM practices across Medicaid Enterprise Systems (MES) and how the use of BerryDunn's OCM Maturity Assessment framework has provided measurable insights that directly support program success. 'Our team members gain valuable perspective by being actively engaged in Medicaid IT and policy planning at the national and state levels,' says Ed Daranyi, BerryDunn Principal and leader of the firm's Medicaid Practice Group. 'We provide those insights and deep industry knowledge to clients across the country, supporting innovation in client solutions.' As BerryDunn celebrates 25 years at MESC, the firm remains committed to helping agencies navigate complexity with clarity, purpose, and innovation. With deep expertise in policy, technology, and program excellence, BerryDunn continues to lead with insight and impact. About BerryDunn BerryDunn is the brand name under which Berry, Dunn, McNeil & Parker, LLC and BDMP Assurance, LLP, independently owned entities, provide services. Since 1974, BerryDunn has helped businesses, nonprofits, and government agencies throughout the US and its territories solve their greatest challenges. The firm's tax, advisory, and consulting services are provided by Berry, Dunn, McNeil & Parker, LLC, and its attest services are provided by BDMP Assurance, LLP, a licensed CPA firm. BerryDunn is a client-centered, people-first professional services firm with a mission to empower the meaningful growth of our people, clients, and communities. Led by CEO Sarah Belliveau, the firm has been recognized for its efforts in creating a diverse and inclusive workplace culture, and for its focus on learning, development, and well-being. Learn more at
